James Mazzo

James Mazzo

James V. (Jim) Mazzo is Executive Chairman of Neurotech, a retinal implant company; and Executive Chairman for Avellino Labs, a biotechnology and genetic science company. He is also Advisor for Zeiss and Advisor for Bain Consulting.
Mazzo is one of the ophthalmic industry’s best known and most respected business leaders with over 40 years of proven experience. His global reputation for building and running world-class organizations is based on 22 years leading Allergan’s North American and European eye care organizations; 7 years as Chairman, President and CEO of Advanced Medical Optics (AMO); 4 years as EVP of Abbott’s global ophthalmology business; 3 years as Executive Chair and CEO of AcuFocus and 4 years as Global President of Ophthalmic Devices for Carl Zeiss Meditec.
Additionally, he is founder and Chairman of OCTANe, is a member of the International Intraocular Implant Club (lllC) and Executive Committee Board Member with the Medical Device Manufacturers Association (MDMA). Mazzo is on the ASCRS Governing Board, the AAO Foundation Advisory Board, the AGS Foundation Advisory Board, a Chair Member of the Gavin Herbert Eye Institute, a Consultant of Anivive Lifesciences, sits on the Board of Visus Therapeutics, Refocus Group, Centricity Vision, LensGen, Iantrek, and Preceyes, serves on NASA’s Mission to Mars Committee, is an Officer in the Order of St. John and a Board Member of the Anaheim Ducks Foundation,
His accomplishments and contributions to the healthcare industry and business and educational communities include serving as Board Chairman for AdvaMed; on the University of California at Irvine foundation; as Vice Chair Trustee Chapman University; years of dedicated experience with the medical device industry including cardiology, orthopedics as well as ophthalmology; recognized as a Top 100 Innovator in Ophthalmology multiple times; and received the 2020 Ellis Island Medal of Honor